SEARCH

PAGETOP

Loss of RUBCN/rubicon in adipocytes mediates the upregulation of autophagy to promote the fasting response

Journal Autophagy 1-11 (2022)
Title Loss of RUBCN/rubicon in adipocytes mediates the upregulation of autophagy to promote the fasting response
Laboratory Laboratory of Intracellular Membrane Dynamics
Abstract

Upon fasting, adipocytes release their lipids that accumulate in the liver, thus promoting hepatic steatosis and ketone body production. However, the mechanisms underlying this process are not fully understood. In this study, we found that fasting caused a substantial decrease in the adipose levels of RUBCN/rubicon, a negative regulator of macroautophagy/autophagy, along with an increase in autophagy. Adipose-specific rubcn-knockout mice exhibited systemic fat loss that was not accelerated by fasting. Genetic inhibition of autophagy in adipocytes in fasted mice led to a reduction in fat loss, hepatic steatosis, and ketonemia. In terms of mechanism, autophagy decreased the levels of its substrates NCOA1/SRC-1 and NCOA2/TIF2, which are also coactivators of PPARG/PPARγ, leading to a fasting-induced reduction in the mRNA levels of adipogenic genes in adipocytes. Furthermore, RUBCN in adipocytes was degraded through the autophagy pathway, suggesting that autophagic degradation of RUBCN serves as a feedforward system for autophagy induction during fasting. Collectively, we propose that loss of adipose RUBCN promotes a metabolic response to fasting via increasing autophagic activity.

Authors

Tadashi Yamamuro (1), Shuhei Nakamura (1, 2, 3), Kyosuke Yanagawa (1, 4), Ayaka Tokumura (1), Tsuyoshi Kawabata (1, 2, 5), Atsunori Fukuhara (6, 7), Hirofumi Teranishi (8), Maho Hamasaki (1, 2), Iichiro Shimomura (6), Tamotsu Yoshimori (1, 2, 9)

  1. Department of Genetics, Graduate School of Medicine, Osaka University, Suita, Japan.
  2. Laboratory of Intracellular Membrane Dynamics, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.
  3. Institute for Advanced Co-Creation Studies, Osaka University, Suita, Japan.
  4. Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University, Suita, Japan.
  5. Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  6. Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Japan.
  7. Department of Adipose Management, Graduate School of Medicine, Osaka University, Suita, Japan.
  8. Pharmaceutical Frontier Research Laboratories, Central Pharmaceutical Research Institute, JT Inc., Yokohama, Japan.
  9. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan.
PubMed 35282767

PAGETOP